Author:
Kitajima Kazuhiro,Maeda Tetsuo,Watanabe Sanae,Ueno Yoshiko,Sugimura Kazuro
Reference29 articles.
1. U.S. Food and Drug Administration Important drug warning for gadolinium-based contrast agents http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM154532.pdf
2. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients;Cowper;Lancet,2000
3. Nephrogenic fibrosing dermopathy with systemic involvement;Ting;Arch. Dermatol.,2003
4. Gadolium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?;Grobner;Nephrol. Dial. Transplant.,2006
5. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis;High;J. Am. Acad. Dermatol.,2007
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献